
Addex Therapeutics is a biotechnology business based in the US. Addex Therapeutics shares (ADXN) are listed on the NASDAQ and all prices are listed in US Dollars. Addex Therapeutics employs 24 staff and has a trailing 12-month revenue of around $1.7 million.
How to buy Addex Therapeutics stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ADXN. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
tastytrade
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 in stock when you fund a new account within 30 days
M1 Finance
- Commission-free stock and ETF trades
- No management fees
- Customizable portfolios with automatic rebalancing
Addex Therapeutics stock price (NASDAQ: ADXN)
Use our graph to track the performance of ADXN stocks over time.Addex Therapeutics shares at a glance
Latest market close | $0.70 |
---|---|
52-week range | $0.55 - $4.00 |
50-day moving average | $0.80 |
200-day moving average | $0.95 |
Wall St. target price | N/A |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-2.52 |
Buy Addex Therapeutics stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Addex Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Addex Therapeutics price performance over time
Historical closes compared with the close of $0.7 from 2023-06-02
1 week (2023-05-26) | -2.78% |
---|---|
1 month (2023-05-05) | -3.71% |
3 months (2023-03-06) | -53.02% |
6 months (2022-12-06) | -2.10% |
1 year (2022-06-06) | -80.00% |
---|---|
2 years (2021-06-04) | -93.00% |
3 years (2020-06-05) | 7.28 |
5 years (2018-06-02) | N/A |
Addex Therapeutics financials
Revenue TTM | $1.7 million |
---|---|
Gross profit TTM | $1.4 million |
Return on assets TTM | -85.87% |
Return on equity TTM | -204.24% |
Profit margin | 0% |
Book value | $0.38 |
Market capitalisation | $11.8 million |
TTM: trailing 12 months
Addex Therapeutics share dividends
We're not expecting Addex Therapeutics to pay a dividend over the next 12 months.
Addex Therapeutics share price volatility
Over the last 12 months, Addex Therapeutics's shares have ranged in value from as little as $0.55 up to $4. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Addex Therapeutics's is 1.6669. This would suggest that Addex Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Addex Therapeutics overview
Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for pain, anxiety, and addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc. ; Indivior PLC; and The Charcot"Marie"Tooth Association. The company was formerly known as Addex Pharmaceuticals Ltd. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland.
Frequently asked questions
What percentage of Addex Therapeutics is owned by institutions?Currently 18.007% of Addex Therapeutics shares are held by institutions. How many people work for Addex Therapeutics?
Latest data suggests 24 work at Addex Therapeutics. When does the fiscal year end for Addex Therapeutics?
Addex Therapeutics's fiscal year ends in December. Where is Addex Therapeutics based?
Addex Therapeutics's address is: Chemin des Mines, 9, Geneva, Switzerland, 1202 What is Addex Therapeutics's ISIN number?
Addex Therapeutics's international securities identification number is: US00654J1079 What is Addex Therapeutics's CUSIP number?
Addex Therapeutics's Committee on Uniform Securities Identification Procedures number is: 00654J107
More guides on Finder
-
JP Morgan Personal Advisors review 2023
Access remote advice, planning and portfolio management from this established financial services company.
-
How to buy Energy Transfer Equity stock
Steps to owning and managing ET, with 24-hour and historical pricing before you buy.
-
How to buy Uranium Energy stock
Steps to owning and managing UEC, with 24-hour and historical pricing before you buy.
-
How to buy Gold Royalty stock
Steps to owning and managing GROY, with 24-hour and historical pricing before you buy.
-
What happens if a brokerage firm fails?
Here’s what happens to your securities if your brokerage fails, and how your assets are protected by SIPC and FDIC.
-
Best online brokers & platforms to buy gold stocks in June 2023
Learn about buying physical gold, plus stocks and ETFs, to learn how you can add gold exposure to your portfolio.
-
Silicon Valley Bank collapse: Which ETFs and stocks are impacted?
Several ETFs have exposure to Silicon Valley Bank, but it appears minimal.
-
How to buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
-
SVB collapses: What does it mean for your portfolio?
The 16th largest US bank has collapsed, but its impact on your portfolio could be limited depending on what you own.
-
How to buy Vanguard VTI Total Stock Market ETF units
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
Ask an Expert